Dental materials based on polymerizable thiourea derivatives

JP2022120823A5Active Publication Date: 2025-01-16IVOCLAR VIVADENT AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2022014656
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-02-05
Filing Date
2022-02-02
Publication Date
2025-01-16
Estimated Expiration
2042-02-02

AI Technical Summary

Technical Problem

Existing dental materials using hydroperoxide-thiourea redox initiator systems suffer from bitterness, poor biocompatibility, and inadequate mechanical properties, particularly in prosthetic materials and cements.

Method used

A radically polymerizable dental material comprising a combination of thiourea derivatives and hydroperoxide, formulated with specific structural variations and optionally including transition metal compounds, to enhance curing properties and mechanical strength while eliminating bitterness.

Benefits of technology

The material achieves non-bitter, biocompatible, and mechanically robust dental compositions suitable for prosthetics and cements, with improved processing and curing times, comparable to established systems but without the taste issues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2022120823000001
    Figure 2022120823000001
  • Figure 2022120823000002
    Figure 2022120823000002
Patent Text Reader

Abstract

To provide dental materials based on polymerizable thiourea derivatives.SOLUTION: Provided is a radically polymerizable dental material, which includes a combination of a hydroperoxide and a thiourea derivative according to the following Formula (I) as initiator system for the radical polymerization: in which R is absent or is an (n+1)-valent, aromatic, aliphatic, linear or branched C1-C50 hydrocarbon radical, which can be interrupted by one or more than one ether, thioether, ester, amide or urethane groups; PG is a radically polymerizable (meth)acrylate, (meth)acrylamide or vinyl group; and n is 1, 2 or 3.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a radically polymerizable composition having a hydroperoxide-thiourea redox initiator system containing a radically polymerizable thiourea derivative. The composition is particularly suitable as a dental material, for example, as a prosthetic material, cement, adhesive, and composite material for direct filling.

Background Art

[0002] The main fields of use of polymers in the dental field are removable prostheses (e.g., teeth and prosthetic base materials) and fixed prostheses (e.g., veneer materials, crowns or cements), filling materials (e.g., direct or indirect filling composite materials, fixed cement or adhesives) or auxiliary materials (e.g., impression materials). Polymers are usually obtained by radical polymerization of a composition containing a polymerizable organic matrix, usually a mixture of monomers, an initiator component and a stabilizer.

[0003] Methyl methacrylate (MMA) (prosthetic material), a mixture of functionalized monomers, such as 2-hydroxyethyl methacrylate (HEMA), or an acid group-containing adhesive monomer, such as 10-methacryloyloxydecyl dihydrogen phosphate (MDP), having a dimethacrylate (adhesive) or a mixture containing only dimethacrylate (composite cement and filling composite material) is usually used as a monomer. Commonly used dimethacrylates are 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropyl)phenyl]propane (bis-GMA) and 1,6-bis-[2-methacryloyloxyethoxycarbonylamino]-2,2,4-trimethylhexane (UDMA), which have a high viscosity and result in polymers having very excellent mechanical properties. In particular, triethylene glycol dimethacrylate (TEGDMA), 1,10-decanediol dimethacrylate (D3MA) or bis(3-methacryloyloxymethyl)tricyclo-[5.2.1.02.6]decane (DCP) is used as a reactive diluent.

[0004] Methacrylate-based dental materials are cured by radical polymerization, and depending on the application area, photoinitiators (photocuring, direct filling composites and adhesives), thermal initiators (indirect composites or prosthetic materials), or redox initiator systems (composite cements) are used. A combination of photoinitiators and redox initiators is also common, for example, in filling materials for deep cavities.

[0005] Redox-based curing agents are used particularly when there is a risk of incomplete hardening, such as in the case of prosthetic materials due to the low reactivity of the monomer, or in the case of cement fixation due to insufficient irradiation.

[0006] To ensure sufficient storage stability of the material, redox initiator-based materials are typically used as a so-called two-component system (2C system), where the oxidizing agent (peroxide or hydroperoxide) and the reducing agent (amine, sulfinic acid, barbiturate, thiourea, etc.) are incorporated into two separate components. These components are mixed together immediately before use. The two components must match to allow for a uniform blend and easy use, and to achieve a sufficient processing time for dental purposes. Processing time refers to the time from blending the two components to the start of hardening of the mixed material. On the other hand, the curing time, i.e., the period until the material is completely cured, should not be too long.

[0007] For a long time, redox initiator systems based on mixtures of dibenzoyl peroxide (DBPO) with tertiary aromatic amines, such as N,N-diethanol-p-toluidine (DEPT), N,N-dimethyl-sym.-xylidine (DMSX), or N,N-diethyl-3,5-di-tert.-butylaniline (DABA), have been primarily used in dental composite cements. In DBPO / amine-based redox initiator systems, processing and curing times can be set relatively appropriately in combination with phenol inhibitors. A drawback of such DBPO / amine systems is discoloration caused by the slow oxidation of the amine. Furthermore, radical formation in DBPO / amine-based redox initiator systems is also impaired by acids, and therefore by acidic monomers, which are commonly used to prepare enamel-dentin adhesives. The amine component is protonated by acid-base reactions, thereby inactivating it.

[0008] The aforementioned drawbacks can be partially overcome with hydroperoxide redox initiator systems, as they do not require a tertiary amine as a reducing agent. Furthermore, hydroperoxides are more thermally stable than peroxides. For example, cumene hydroperoxide has a half-life of 10 hours and a temperature of T 1 / 2 The temperature is 158°C, and the half-life temperature of DBPO at 10 hours is T 1 / 2 It is only 73°C.

[0009] DE2635595C2 discloses a polymerizable dental filling compound containing a substituted thiourea reducing agent in combination with a hydroperoxide oxidizing agent as an initiator system. The material is said to have improved color stability and shelf life, as well as a good curing rate.

[0010] EP1693046B1 discloses dental cements and core build-up materials comprising a (2-pyridyl)-2-thiourea derivative in combination with a hydroperoxide, wherein the hydroperoxide group is bonded to a tertiary carbon atom.

[0011] WO2007 / 016508A1 discloses polymerizable dental compositions comprising a thiourea derivative in combination with a hydroperoxide as an initiator system. The compositions do not contain monomers having acidic groups.

[0012] According to EP1754465B1, the reactivity of the cumene hydroperoxide / acetylthiourea system can be increased by the addition of a soluble copper compound.

[0013] US7,275,932B2 proposes the use of hydroperoxides and thiourea derivatives in combination with acidic compounds as accelerators. Preferred acidic compounds are acrylates and methacrylates having an acidic group, such as methacrylic acid.

[0014] EP2233544A1 and EP2258336A1 disclose dental materials containing hydroperoxides and thiourea derivatives in combination with vanadium compounds as accelerators.

[0015] WO03 / 057792A2 discloses dental materials containing polymerizable thiourea derivatives such as allylthiourea, 1-allyl-3-(2-hydroxyethyl)-2-thiourea, or 4-oxo-9-thioxo-5-oxa-3,8,10-triazatrideca-12-en-1-yl methacrylate as reducing agents. These are intended to have a lower risk of potential toxic or anesthetic side effects.

[0016] Initiator systems based on hydroperoxides and thiourea derivatives have gained considerable importance in avoiding the drawbacks of peroxide / amine systems. The drawback is that many thiourea derivatives have a strong bitter taste (D. Mela, Chem. Senses 14 (1989) 131-135; Lange et al., Chem. Amer. Chem. Soc. 51 (1929) 1911-1914; Qin et al., Talanta 199 (2019) 131-139), which remains noticeable even after hardening and causes discomfort to many patients. [Prior art documents] [Patent Documents]

[0017] [Patent Document 1] German Patent No. 2635595 Specification [Patent Document 2] European Patent No. 1693046 [Patent Document 3] International Publication No. 2007 / 016508 [Patent Document 4] European Patent No. 1754465 [Patent Document 5] U.S. Patent No. 7,275,932 [Patent Document 6] European Patent Application Publication No. 2233544 [Patent Document 7] European Patent Application Publication No. 2258336 [Patent Document 8] International Publication No. 03 / 057792 [Non-patent literature]

[0018] [Non-Patent Document 1] D. Mela, Chem. Senses 14 (1989) 131-135 [Non-Patent Document 2] Lange et al., Chem. Amer. Chem. Soc. 51 (1929) 1911-1914 [Non-Patent Document 3] Qin et al., Talanta 199 (2019) 131-139 [Overview of the project] [Means for solving the problem]

[0019] The objective of this invention is to provide a dental material that does not have the drawbacks of cutting-edge technology. The material must be free of bitterness, possess excellent biocompatibility and hardening properties, and have excellent mechanical properties. This specification provides, for example, the following: (Reclaim) (Item 1) A radically polymerizable dental material comprising a combination of a thiourea derivative and a hydroperoxide as an initiator system for radical polymerization, wherein the following formula (I): [ka] (In the formula, the variables have the following meanings: R may be absent, or one or more than one, preferably 1 to 8, particularly preferably 1 to 6, ether, thioether, ester, amide, or urethane groups, (n+1) valence, aromatic, aliphatic, linear or branched C1-C 50 It is a hydrocarbon radical, PG is a radically polymerizable (meth)acrylate, (meth)acrylamide, or vinyl group. n is 1, 2, or 3. A radically polymerizable dental material characterized by containing a thiourea derivative. (Item 2) The above variable has the following meaning: R may be interposed by one or more, preferably 1 to 6, particularly preferably 1 to 3, ether, ester, or urethane groups, (n+1) valence, aromatic, aliphatic, linear or branched C1-C 30 It is a hydrocarbon radical, PG is a radically polymerizable methacrylate, methacrylamide, or vinyl group. n is either 1 or 2. A dental material having the characteristics described in any one of the preceding items. (Item 3) The above variable has the following meaning: R is a (n + 1)-valent, aromatic, aliphatic, straight-chain or branched C1-C hydrocarbon radical which can be interrupted by 1 to 6 ether groups or one ester or urethane group, 20 and PG is a radically polymerizable methacrylate or a vinyl group, n is 1, or R is a phenylene radical, preferably a p-phenylene radical, or a radical having the formula -Ph-CH2-, PG is a vinyl group, n is 1 A dental material according to any one of the preceding items having (Item 4) The compound of formula R 1 (OOH) m as a hydroperoxide, wherein R 1 is an aliphatic or aromatic hydrocarbon radical and m is 1 or 2. A dental material according to any one of the preceding items. (Item 5) A dental material according to any one of the preceding items containing t-amyl hydroperoxide, 1,1,3,3-tetramethylbutyl hydroperoxide, t-butyl hydroperoxide, t-hexyl hydroxyperoxide, 2,5-dimethyl-2,5-di(hydroperoxy)hexane, diisopropylbenzene monohydroperoxide, paramethane hydroperoxide, p-isopropylcumene hydroperoxide or a mixture thereof, preferably cumene hydroperoxide (CHP) as a hydroperoxide. (Item 6) The following formula (II), [Chemical formula] (wherein the variables have the following meanings: Q 1 can be interrupted by one or more S and / or O atoms and is unsubstituted or preferably -OH, -OR 2C1-C1 atoms can be substituted with one or more substituents selected from -Cl and -Br, and are p-valent, aromatic, aliphatic, linear or branched. 14 A hydrocarbon radical, where R 2 These are aliphatic, linear, or branched C1-C. 10 It is a hydrocarbon radical, X and Y are independent of each other and do not exist in either case, -O-, -COO-, -CONR 3 -, or -O-CO-NR 4 -and here, R 3 and R 4 These independently represent H or C1-C5 alkyl radicals, preferably H, methyl and / or ethyl, particularly preferably H, and X and Y are preferably not present at the same time. Q 2 It does not exist or may be interrupted by S and / or O atoms, unsubstituted or -OH, -OR 5 Aliphatic, linear or branched C1-C, which can be substituted with -Cl and / or -Br. 14 It is an alkylene radical, and here, R 5 These are aliphatic, linear, or branched C1-C cells. 10 It is a hydrocarbon radical, Q 3 is a C1-C3 alkylene group or absent, preferably -CH2- or absent. Here, Q 2 If it does not exist, then X and / or Y do not exist. p is 1, 2, 3, or 4. And here The substituents in the aromatic compound occur at positions 2, 3, or 4. Dental materials as described in any one of the preceding items, including hydroperoxides. (Item 7) A dental material according to any one of the preceding items, further comprising a transition metal compound, preferably a transition metal compound having at least two stable oxidation states, preferably a compound of copper, iron, cobalt, nickel, manganese, or a mixture thereof. (Item 8) 0.001 to 5% by weight, particularly preferably 0.005 to 3.0% by weight, and very particularly preferably 0.1 to 3.0% by weight, at least one thiourea derivative of formula (I), 0.01 to 5% by weight, preferably 0.05 to 4.0% by weight, and particularly preferably 0.1 to 3.0% by weight of hydroperoxide, If necessary, 0.0001 to 1% by weight, preferably 0.0005 to 0.5% by weight, and particularly preferably 0.0007 to 0.020% by weight of a transition metal compound, Dental materials, including, in any case, the dental materials described in any one of the preceding items, which are relative to the total mass of the material. (Item 9) A dental material according to any one of the preceding items, further comprising at least one radically polymerizable monomer, preferably at least one mono- or polyfunctional (meth)acrylate, particularly preferably at least one dimethacrylate or a mixture of mono- and dimethacrylates. (Item 10) As radically polymerizable monomers, methyl, ethyl, 2-hydroxyethyl, butyl, benzyl, tetrahydrofurfuryl or isobornyl (meth)acrylate, p-cumylphenoxyethylene glycol methacrylate (CMP-1E), 2-(2-biphenyloxy)ethyl methacrylate, bisphenol A dimethacrylate, bis-GMA (addition product of methacrylic acid and bisphenol A diglycidyl ether), ethoxylated or propoxylated bisphenol A. Phenol A dimethacrylate, 2-[4-(2-methacryloyloxyethoxyethoxy)phenyl]-2-[4-(2-methacryloyloxyethoxy)phenyl]propane (SR-348c), 2,2-bis[4-(2-methacryloyloxypropoxy)phenyl]propane, UDMA (addition product of 2-hydroxyethyl methacrylate and 2,2,4-trimethylhexamethylene-1,6-diisocyanate), V-380 (0.7 mol of 2-hydroxyethyl methacrylate) Dental materials as described in any one of the preceding items, comprising methacrylate and an addition product of a mixture of 0.3 mol of 2-hydroxypropyl methacrylate and 1 mol of α,α,α',α'-tetramethyl-m-xylylene diisocyanate), di-, tri- or tetraethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, pentaerythritol tetramethacrylate, glycerol di- and trimethacrylate, 1,4-butanediol dimethacrylate, 1,10-decanediol dimethacrylate (D3MA), bis(methacryloyloxymethyl)tricyclo-[5.2.1.02,6]decane (DCP), polyethylene glycol or polypropylene glycol dimethacrylate, polyethylene glycol 200 dimethacrylate, polyethylene glycol 400 dimethacrylate (PEG200DMA or PEG400DMA), 1,12-dodecanediol dimethacrylate, or mixtures thereof. (Item 11) A dental material according to any one of the preceding items, further comprising at least one acid group-containing radical polymerizable monomer, preferably a polymerizable carboxylic acid, a phosphonic acid, a polymerizable phosphate ester, or an anhydride of these substances. (Item 12) A dental material according to any one of the preceding items, further comprising at least one organic or inorganic filler, preferably a monooxide, for example SiO2, ZrO2 and TiO2, or a mixed oxide of SiO2, ZrO2, ZnO and / or TiO2, nanoparticles or microfine fillers, for example exothermic silica or precipitated silica, glass powder, for example quartz, glass ceramic or radiopaque glass powder, preferably barium or strontium aluminum silicate glass powder, radiopaque filler, for example ytterbium trifluoride, tantalum(V) oxide, barium sulfate, ytterbium(III) oxide or a mixed oxide of SiO2 with tantalum(V) oxide, or a pulverized prepolymer or pearl polymer. (Item 13) (a) 0.001 to 5.0% by weight, preferably 0.005 to 3.0% by weight, and particularly preferably 0.1 to 3.0% by weight of at least one thiourea derivative of formula (I), (b) At least one hydroperoxide in an amount of 0.01 to 5.0% by weight, preferably 0.05 to 4.0% by weight, and particularly preferably 0.1 to 3.0% by weight, (c) 5 to 95% by weight, preferably 10 to 95% by weight, and particularly preferably 10 to 90% by weight of at least one radical polymerizable monomer, (d) Fillers (multiple) in an amount of 0-80% by weight, and (e) Additives (multiple amounts possible) in an amount of 0.01 to 5% by weight, preferably 0.1 to 3% by weight, and particularly preferably 0.1 to 2% by weight. This includes, and in all cases, it is relative to the total mass of the material. Dental materials as described in any one of the preceding items. (Item 14) Dental materials as described in any one of the preceding items, comprising 50-80% by weight (filling composite material), 10-70% by weight (cement), or 0-10% by weight of a filling agent (prosthetic material). (Item 15) A dental material as described in any one of the preceding items, preferably for therapeutic use, as a dental cement, filling composite material, or veneer material. (Item 16) Preferably, non-therapeutic use of the dental materials described in any one of the preceding items for the manufacture or repair of dental restorations such as prostheses, artificial teeth, inlays, onlays, crowns, bridges and complete dentures. [Modes for carrying out the invention]

[0020] The initiator system for radical polymerization is given by the following formula (I): [ka] (In the formula, R is absent, or may be one or more, and may be interposed by an ether, thioether, ester, amide or urethane group, (n+1) valency, aromatic, aliphatic, linear or branched C1-C) 50 It is a hydrocarbon radical; PG is a radically polymerizable (meth)acrylate, (meth)acrylamide, or vinyl group; n is 1, 2, or 3. A radically polymerizable dental material containing a combination of hydroperoxide and thiourea derivatives. The objective is to use the following formula (I): as an initiator system for radical polymerization. [ka] (wherein R is absent or may be interposed by one or more, preferably 1 to 8, particularly preferably 1 to 6, ether, thioether, ester, amide or urethane groups, (n+1) valence, aromatic, aliphatic, linear or branched C1-C) 50 It is a hydrocarbon radical, PG is a radically polymerizable (meth)acrylate, (meth)acrylamide, or vinyl group. n is 1, 2, or 3. This is achieved by radically polymerizable dental materials, including combinations of hydroperoxides and thiourea derivatives.

[0021] The variables preferably have the following meanings: R may be interposed by one or more, preferably 1 to 6, particularly preferably 1 to 3, ether, ester, or urethane groups, (n+1) valence, aromatic, linear or branched C1-C 20 It is a hydrocarbon radical, PG is a radically polymerizable methacrylate or vinyl group. n is either 1 or 2.

[0022] The variables preferably have the following meanings: R can be interposed by 1 to 6 ether groups, or 1 ester or urethane group, and is (n+1) valent, aromatic, aliphatic, linear or branched C1-C. 20 It is a hydrocarbon radical, PG is a radically polymerizable methacrylate or vinyl group. Is n 1? or R is a phenylene radical, preferably a p-phenylene radical, or a radical having the formula -Ph-CH2-. PG is a vinyl group, n is 1 Here, if R is -Ph-CH2-, the vinyl group is bonded to the phenyl radical (Ph): H2C=CH-Ph-CH2-.

[0023] All formulas shown in this specification are extended only to these compounds compatible with the theory of chemical valence. The indication that a radical is intercepted by, for example, one or more ether groups should be understood as meaning that these groups are inserted into the carbon chain of the radical in each case. Thus, these groups are adjacent to C atoms on both sides and cannot be terminal. C1 radicals cannot be intercepted. Corresponding to common nomenclature, aromatic hydrocarbon radicals also refer to these radicals containing aromatic and non-aromatic groups. A preferred aromatic radical is, for example, -Ph-CH2-.

[0024] The preferred, particularly preferred, and very particularly preferred definitions given to each variable can be selected independently of each other in each case. Compounds in which all variables have preferred, particularly preferred, and very particularly preferred definitions are, of course, particularly suitable according to the present invention.

[0025] Although the thiourea derivatives of formula I are not publicly known, they may be prepared using known synthetic methods. For example, polymerizable benzoyl and acetylthiourea derivatives can be prepared by reacting the corresponding polymerizable acid chlorides with thiourea at high temperatures. 1st step [ka] Specific example: [ka] 2nd process [ka] Specific example: [ka] The polymerizable thiourea derivative of preferred formula (I) according to the present invention is [ka] [ka] [ka] That is the case.

[0026] The polymerizable thiourea derivative of formula (I) according to the present invention is used in combination with a hydroperoxide.

[0027] A preferred hydroperoxide according to the present invention is of formula R 1 -(OOH) m It is a compound of R, where 1 R is an aliphatic or aromatic hydrocarbon radical, where m is 1 or 2. Preferred radical R 1 These are alkyl and aryl groups. Alkyl groups can be linear, branched, or cyclic. Cyclic alkyl radicals can be substituted with aliphatic alkyl groups. Alkyl groups having 4 to 10 carbon atoms are preferred. Aryl groups can be unsubstituted or substituted with alkyl groups. Preferred aromatic hydrocarbon radicals are benzene radicals substituted with one or two alkyl groups. Aromatic hydrocarbon radicals preferably contain 6 to 12 carbon atoms. Particularly preferred hydroperoxides are t-amyl hydroperoxide, 1,1,3,3-tetramethylbutyl hydroperoxide, t-butyl hydroperoxide, t-hexyl hydroperoxide, 2,5-dimethyl-2,5-di(hydroperoxy)hexane, diisopropylbenzene monohydroperoxide, paramentane hydroperoxide, p-isopropylcumene hydroperoxide, and mixtures thereof. Cumene hydroperoxide (CHP) is very particularly preferred.

[0028] A low-odor CHP derivative, as disclosed in European patent application EP3692976A1 for formula II, is even more preferred. [ka] In the formula, the variables have the following meanings: Q 1It can be interrupted by one or more S and / or O atoms, and is unsubstituted, or preferably -OH, -OR 2 C1-C1 atoms can be substituted with one or more substituents selected from -Cl and -Br, and are p-valent, aromatic, aliphatic, linear or branched. 14 A hydrocarbon radical, where R 2 These are aliphatic, linear, or branched C1-C. 10 It is a hydrocarbon radical, X and Y are independent of each other and do not exist in either case, -O-, -COO-, -CONR 3 -, or -O-CO-NR 4 -and here, R 3 and R 4 These independently represent H or C1-C5 alkyl radicals, preferably H, methyl and / or ethyl, particularly preferably H, and X and Y are preferably not present at the same time. Q 2 It does not exist, can be interrupted by S and / or O atoms, unsubstituted or -OH, -OR 5 Can be substituted with -Cl and / or -Br, aliphatic, linear or branched C1-C 14 It is an alkylene radical, and here, R 5 These are aliphatic, linear, or branched C1-C cells. 10 It is a hydrocarbon radical, Q 3 is a C1-C3 alkylene group or absent, preferably -CH2- or absent. Here, if Q2 does not exist, then X and / or Y do not exist. p is 1, 2, 3, or 4. And here Substituents on aromatic compounds occur at the 2nd, 3rd, or 4th position relative to the cumene hydroperoxide group.

[0029] The variables preferably have the following meanings: Q 1It may be interrupted by one or more oxygen atoms, preferably one oxygen atom, and one or more, preferably one, -OH and -OR 2 Monovalent or divalent, aliphatic, linear or branched C1-C atoms, substituted with substituents selected from, or preferably unsubstituted. 10 It is a hydrocarbon radical, where R 2 These are aliphatic, linear, or branched C1-C6 hydrocarbon radicals. X and Y are independent of each other and do not exist in either case: -O-, -COO-, or OCONR 4 -, here, R 4 is H or a C1-C5 alkyl radical, preferably H, methyl and / or ethyl, and very particularly preferably H, where X and Y are preferably not present at the same time. Q2 is not present, and may be interrupted by one or more oxygen atoms, preferably one or more oxygen atoms, -OH and -OR 5 Linear or branched C1-C1 chains may be substituted with one or more substituents selected from the following, preferably one substituent, or may be unsubstituted. 10 It is an alkylene radical, and here R 5 It is an aliphatic, linear, or branched C1-C6 hydrocarbon radical. p is 1 or 2, and here Substitution on aromatic compounds occurs at the 3rd position, preferably the 4th position.

[0030] The variables preferably have the following meanings: Q 1 It is a monovalent or divalent, aliphatic, linear or branched C1-C5 hydrocarbon radical that can be interposed by one oxygen atom and substituted by one OH group. X is the COO, Y does not exist. Q 2 Either it does not exist, or it is a linear C1-C3 alkylene radical. p is either 1 or 2, and substitution on the aromatic compound occurs at position 4. The variables preferably have the following meanings: Q 1 It is a monovalent or divalent, aliphatic, branched, preferably linear C1-C4 hydrocarbon radical. X is the COO, Y does not exist. Q 2 It does not exist, or it is a methylene radical. p is either 1 or 2, where substitution on the aromatic compound occurs at position 4.

[0031] The preferred hydroperoxide derivative of formula II according to the present invention is [ka] [ka] [ka] [ka] That is the case.

[0032] The hydroperoxide derivative of Formula II exhibits excellent storage stability at room temperature and is particularly suitable as a low-odor hydroperoxide component in redox initiator systems for dental compositions. The material according to the present invention may contain one or more hydroperoxides.

[0033] In a more preferred embodiment, the dental material according to the present invention further comprises at least one transition metal compound in addition to at least one hydroperoxide of formula I and at least one thiourea derivative. It has been found that the addition of a transition metal compound results in a material with significantly improved mechanical properties after hardening.

[0034] The preferred transition metal compounds according to the present invention are compounds derived from transition metals having at least two stable oxidation states. Compounds of the elements copper, iron, cobalt, nickel, and manganese are particularly preferred. These metals have the following stable oxidation states: Cu(I) / Cu(II), Fe(II) / Fe(III), Co(II) / Co(III), Ni(II) / Ni(III), Mn(II) / Mn(III). Materials containing at least one copper compound are particularly preferred.

[0035] Transition metals are preferably used in the form of their salts. Preferred salts are nitrates, acetates, 2-ethylhexane salts, and halides, with chlorides being particularly preferred.

[0036] Transition metals can also be advantageously used in complex form, and complexes with chelate-forming ligands are particularly preferred. Preferred simple ligands for complexing transition metals are 2-ethylhexanoate and THF. Preferred chelate-forming ligands are 2-(2-aminoethylamino)ethanol, aliphatic amines, particularly preferably 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), N,N,N',N'',N'',N''pentamethyldiethylenetriamine (PMDETA), tris[2-(dimethylamino)ethyl]amine (Me6TREN), N,N,N',N'-tetramethylethylenediamine (TMEDA), and 1,4,8,11-tetraaza-1,4,8,11-tetramethylcyclotetra The ligands include decane (Me4CYCLAM), diethylenetriamine (DETA), triethylenetetramine (TETA), and 1,4,8,11-tetraazacyclotetradecane (CYCLAM); pyridine-containing ligands, particularly preferably N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), N,N-bis(2-pyridylmethyl)amine (BPMA), N,N-bis(2-pyridylmethyl)octylamine (BPMOA), 2,2'-bipyridine, and 8-hydroxyquinoline. Particularly preferred ligands are acetylacetone, dimethylglyoxime, and 1,10-phenanthroline.

[0037] In the case of electrically neutral ligands, the charge of the transition metal ion needs to be balanced by a suitable counterion. For this reason, the above ions used to form salts are given special consideration, where acetates and chlorides are particularly preferred. Chlorides and complexes are characterized by relatively good solubility in monomers used in the preparation of dental materials.

[0038] Instead of transition metal complexes, non-complex salts of transition metals can be used in combination with complex-forming organic compounds, preferably in combination with the chelate-forming compounds mentioned above, to prepare dental materials. When the organic ligand is mixed with the transition metal salt, it forms a catalytically active complex. The use of such combinations of transition metal salts and organic ligands is preferred.

[0039] Metallic copper, preferably Cu + , iron, preferably Fe 3+ , cobalt, preferably Co 3+ , and nickel, preferably tart 2+ A transition metal compound is preferred.

[0040] Preferred copper salts are Cu(II) carboxylates (e.g., acetic acid or 2-ethylhexanoic acid), CuCl2, CuBr2, CuI2, particularly preferably CuBr, and very particularly preferably CuCl. Preferred copper complexes are complexes with the ligand acetylacetone, phenanthroline (e.g., 1,10-phenanthroline (phen)), and aliphatic amines such as 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA), N,N,N',N'',N''-pentamethyldiethylenetriamine (PMDETA), and tris[2-(dimethylamino)ethyl]amine (Me6TREN).

[0041] Preferred iron salts are FeCl3, FeBr2, and FeCl2. Preferred iron complexes are ligands acetylacetone, triphenylphosphine, 4,4'-di(5-nonyl)-2,2'-bipyridine (dNbpy), or 1,3-diisopropyl-4,5-dimethylimidazole-2-ylidene (PriIm). Complexes Fe(acac)2 and FeCl2(PPh3)2 are particularly preferred.

[0042] Preferred nickel salts are NiBr2 and NiCl2, and preferred nickel complexes are nickel acetylacetonate and NiBr2(PPh3)2.

[0043] According to the present invention, copper compounds, copper complexes, and especially mixtures of copper salts and complexing organic ligands are particularly preferred. Monovalent copper (Cu + Salts and complexes of copper(II) are very preferably, with copper(I) chloride (CuCl) being the most preferred. Compositions containing monovalent copper salts, especially CuCl, are characterized by particularly good storage stability.

[0044] The material according to the present invention preferably contains 0.001 to 5% by weight, particularly preferably 0.005 to 3.0% by weight, and very particularly preferably 0.1 to 3.0% by weight of at least one thiourea derivative of formula (I).

[0045] Hydroperoxides are used in (total) amounts of preferably 0.01 to 5% by weight, particularly preferably 0.05 to 4.0% by weight, and very particularly preferably 0.1 to 3.0% by weight.

[0046] Transition metal compounds are used, where applicable, preferably in amounts of 0.0001 to 1% by weight, preferably 0.0005 to 0.5% by weight, and particularly preferably 0.0007 to 0.020% by weight.

[0047] Unless otherwise specified, all percentages in this specification refer to the total mass of the composition.

[0048] Thiourea derivatives of formula (I), when combined with at least one hydroperoxide, are particularly suitable for curing radically polymerizable compositions.

[0049] The material according to the present invention preferably comprises at least one radically polymerizable monomer. A composition comprising at least one monofunctional or polyfunctional (meth)acrylate as the radically polymerizable monomer is particularly preferred. Monofunctional (meth)acrylate means a compound having one, and polyfunctional (meth)acrylate means a compound having two or more, preferably two to four, radically polymerizable groups. According to a very particularly preferred embodiment, the composition according to the present invention comprises at least one dimethacrylate or a mixture of mono and dimethacrylates. The material cured in the oral cavity preferably comprises mono and / or polyfunctional methacrylate as the radically polymerizable monomer.

[0050] Preferred monofunctional or polyfunctional (meth)acrylates include methyl, ethyl, 2-hydroxyethyl, butyl, benzyl, tetrahydrofurfuryl or isobornyl (meth)acrylate, p-cumylphenoxyethylene glycol methacrylate (CMP-1E), 2-(2-biphenyloxy)ethyl methacrylate, bisphenol A dimethacrylate, bis-GMA (addition product of methacrylic acid and bisphenol A diglycidyl ether), ethoxylated or propoxylated. Dimethacrylate, e.g., 2-[4-(2-methacryloyloxyethoxyethoxy)phenyl]-2-[4-(2-methacryloyloxyethoxy)phenyl]propane) (SR-348c, manufactured by Sartomer, containing three ethoxy groups) and 2,2-bis[4-(2-methacryloxypropoxy)phenyl]propane, UDMA (addition product of 2-hydroxyethyl methacrylate and 2,2,4-trimethylhexamethylene-1,6-diisocyanate) ), V-380 (addition product of a mixture of 0.7 mol of 2-hydroxyethyl and 0.3 mol of 2-hydroxypropyl methacrylate and 1 mol of α,α,α',α'-tetramethyl-m-xylylene diisocyanate), di-, tri- or tetraethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, pentaerythritol tetramethacrylate, and glycerol di-trimethacrylate, 1,4-butanediol dimethacrylate, 1,10-decanediol dimethacrylate (D3MA), bis(methacryloyloxymethyl)tricyclo-[5.2.1.02,6]decane (DCP), polyethylene glycol or polypropylene glycol dimethacrylate, for example, polyethylene glycol 200 dimethacrylate or polyethylene glycol 400 dimethacrylate (PEG200DMA or PEG400DMA) or 1,12-dodecanediol dimethacrylate, or mixtures thereof.

[0051] According to one embodiment, the composition according to the present invention preferably further comprises, in addition to the above monomers, one or more acid group-containing radical polymerizable monomers (adhesive monomers). These impart self-adhesive and / or self-etching properties to the material. Therefore, acid group-containing monomers are particularly suitable for the preparation of self-adhesive dental materials, such as fixing cements.

[0052] Preferred acid group-containing monomers are polymerizable carboxylic acids, phosphonic acids and phosphate esters, and their anhydrides. Preferred carboxylic acids and carboxylic acid anhydrides are 4-(meth)acryloyloxyethyl trimellitic anhydride, 10-methacryloyloxydecylmalonic acid, N-(2-hydroxy-3-methacryloyloxypropyl)-N-phenylglycine, and 4-vinylbenzoic acid. Preferred phosphate esters are 2-methacryloyloxyethylphenyl hydrogen phosphate, 10-methacryloyloxydecyl dihydrogen phosphate (MDP), and dipentaerythritol pentamethacryloyloxyphosphate. Preferred phosphonic acids are 4-vinylbenzylphosphonic acid, 2-[4-(dihydroxyphosphoryl)-2-oxa-butyl]acrylic acid, and their amides, such as esters of 2-[4-(dihydroxyphosphoryl)-2-oxa-butyl]acrylic acid-2,4,6-trimethylphenyl ester.

[0053] Particularly preferred acid group-containing monomers are 4-vinylbenzylphosphonic acid, 2-[4-(dihydroxyphosphoryl)-2-oxa-butyl]acrylic acid and their amides, esters such as 2-[4-(dihydroxyphosphoryl)-2-oxa-butyl]acrylic acid-2,4,6-trimethylphenyl ester, (meth)acrylamide dihydrogen phosphates such as 6-methacrylamide hexyl or 1,3-bis(methacrylamide)-propane-2-yl phosphate dihydrogen phosphate, and mixtures thereof. These particularly preferred acid group-containing monomers are characterized by high hydrolysis stability.

[0054] The compositions according to the present invention may, in addition to the initiator system according to the present invention, advantageously further contain initiators for radical photopolymerization. Such compositions are double-curable, i.e., they can be cured both chemically and by light. Preferred photoinitiators are benzophenones, benzoins, and their derivatives, α-diketones, and their derivatives, e.g., 9,10-phenanthrenequinone, 1-phenyl-propane-1,2-dione, diacetyl, and 4,4'-dichlorobenzyl. Camphorquinone (CQ) and 2,2-dimethoxy-2-phenylacetophenone are preferably used as reducing agents in combination with amines, e.g., ethyl-4-(dimethylamino)benzoate (EDMAB), or N,N-dimethylaminoethyl methacrylate.

[0055] According to the present invention, these compositions that do not contain amines are preferred. Therefore, Norrish type I photoinitiators are particularly preferred. Norrish type I photoinitiators do not require an amine component.

[0056] Preferred Norrish type I photoinitiators are acyl or bisacylphosphine oxides. Monoacyltrialkylgermanium, diacyldialkylgermanium, and tetraacylgermanium compounds, such as benzoyltrimethylgermanium, dibenzoyldiethylgermanium, bis(4-methoxybenzoyl)diethylgermanium (iboselin®), tetrabenzoylgermanium, and tetrakis(o-methylbenzoyl)germanium are particularly preferred.

[0057] Furthermore, mixtures of different photoinitiators may be used; for example, bis(4-methoxybenzoyl)diethylgermanium or tetrakis(o-methylbenzoyl)germanium may also be used in combination with camphorquinone and ethyl 4-dimethylaminobenzoate.

[0058] The dental materials according to the present invention may further, advantageously, contain one or more organic or inorganic fillers. Particulate fillers are preferred. The filler-containing compositions are particularly suitable as dental fixation cements or filling composite materials.

[0059] Preferred inorganic fillers include oxides such as SiO2, ZrO2, and TiO2, or mixed oxides of SiO2, ZrO2, ZnO, and / or TiO2; nanoparticles or microfine fillers such as exothermic silica or precipitated silica; glass powders such as quartz, glass ceramics, borosilicate, or radiopaque glass powder, preferably barium or strontium aluminum silicate glass; and radiopaque fillers such as ytterbium trifluoride, tantalum(V) oxide, barium sulfate, or mixed oxides of SiO2 with ytterbium(III) oxide or tantalum(V) oxide. The dental materials according to the present invention may further include fibrous fillers, nanofibers, whiskers, or mixtures thereof. According to a preferred embodiment, the materials according to the present invention do not include fluoroaluminosilicate glass, calcium aluminum silicate glass, or other fillers that react with organic acids in the sense of an acid-base reaction.

[0060] Preferably, the oxide has a particle size of 0.010 to 15 μm, the nanoparticles or microfine fillers have a particle size of 10 to 300 nm, the glass powder has a particle size of 0.01 to 15 μm, preferably 0.2 to 1.5 μm, and the radiopaque filler has a particle size of 0.2 to 5 μm.

[0061] Particularly preferred fillers are mixed oxides of SiO2 and ZrO2 having a particle size of 10 to 300 nm, glass powders having a particle size of 0.2 to 1.5 μm, in particular radiopaque glass powders of barium or strontium aluminum silicate glass, and radiopaque fillers having a particle size of 0.2 to 5 μm, in particular mixed oxides of ytterbium trifluoride and / or ytterbium(III) oxide and SiO2.

[0062] Furthermore, pulverized prepolymers or pearl polymers (isofillers) are suitable as fillers. These may consist solely of organic polymers, or of organic polymers that are themselves filled with radiopaque glass powders and inorganic fillers such as ytterbium trifluoride. The monomers and fillers defined above are suitable for the preparation of pulverized prepolymers and pearl polymers. Compositions for manufacturing complete dentures preferably consist solely of organic fillers, particularly preferably pulverized polymers or pearl polymers based on polymethyl methacrylate (PMMA), and very particularly preferably pearl polymers based on PMMA as fillers. According to preferred embodiments, the materials according to the present invention do not contain polymers having acidic groups, particularly polymers having carboxylic acid groups.

[0063] Unless otherwise specified, all particle sizes are weight-average particle sizes, where particle size determination in the range of 0.1 μm to 1000 μm is performed by static light scattering, preferably using an LA-960 static laser scattering particle size analyzer (Horiba, Japan). In this specification, a laser diode with a wavelength of 655 nm and an LED with a wavelength of 405 nm are used as light sources. By using two light sources of different wavelengths, the entire size distribution of the sample can be measured in only one measurement pass, where the measurement is performed as a wet measurement. For this purpose, an aqueous dispersion of 0.1 to 0.5% of the packing material is prepared, and its scattered light is measured in a flow cell. Scattered light analysis for calculating particle size and particle size distribution is performed according to Mie theory according to DIN / ISO 13320.

[0064] Particle sizes smaller than 0.1 μm are preferably determined by dynamic light scattering (DLS). Measurement of particle sizes in the range of 5 nm to 0.1 μm is preferably performed by dynamic light scattering (DLS) of an aqueous particle dispersion, preferably using a Malvern Zetasiser Nano ZS (Malvern Instruments, Malvern UK) with a He-Ne laser having a wavelength of 633 nm, a scattering angle of 90°, and a temperature of 25°C.

[0065] As particle size decreases, light scattering decreases. Particle sizes smaller than 0.1 μm can also be determined by SEM or TEM spectroscopy. Transmission electron microscopy (TEM) is preferably performed using a Philips CM30 TEM with an accelerating voltage of 300 kV. For sample preparation, droplets of the particle dispersion are spread onto a 50 A thick copper grid (mesh size 300) coated with carbon, and then the solvent is evaporated.

[0066] Fillers are classified into macrofillers and microfillers according to their particle size, where fillers with an average particle size of 0.2 to 10 μm are called macrofillers, and fillers with an average particle size of approximately 5 to 100 nm are called microfillers. Macrofillers are obtained, for example, by crushing quartz, radiopaque glass, borosilicate glass, or ceramics, and usually consist of fragments. Microfillers, such as mixed oxides, can be prepared, for example, by hydrolytic co-condensation of metal alkoxides. Fillers with smaller particle sizes have a greater thickening effect.

[0067] To improve the bonding between the filler particles and the crosslinked polymerization matrix, the filler is surface-modified, particularly preferably by silanization, very preferably by a radically polymerizable silane, and especially preferably with 3-methacryloyloxypropyltrimethoxysilane. For surface modification of non-silicate fillers, e.g., ZrO2 or TiO2, functionalized acidic phosphates, e.g., 10-methacryloyloxydecyl dihydrogen phosphate may also be used.

[0068] Furthermore, the dental material according to the present invention may contain one or more additional additives, in particular stabilizers, colorants, bactericidal active ingredients, fluoride ion-releasing additives, foaming agents, fluorescent whitening agents, plasticizers, and / or UV absorbers. The material according to the present invention may also contain one or more organic or inorganic solvents as additives. However, according to a preferred embodiment, the material according to the present invention does not contain water.

[0069] (a) 0.001 to 5.0% by weight, preferably 0.005 to 3.0% by weight, and particularly preferably 0.1 to 3.0% by weight of at least one thiourea derivative of formula (I), (b) At least one hydroperoxide in an amount of 0.01 to 5.0% by weight, preferably 0.05 to 4.0% by weight, and particularly preferably 0.1 to 3.0% by weight, (c) 5 to 95% by weight, preferably 10 to 95% by weight, and particularly preferably 10 to 90% by weight of at least one radical polymerizable monomer, (d) 0-80% by weight of filler, and (e) Additives in an amount of 0.01 to 5% by weight, preferably 0.1 to 3% by weight, and particularly preferably 0.1 to 2% by weight. Dental materials containing the present invention are preferred.

[0070] All quantities in this specification are relative to the total mass of the composition unless otherwise specified.

[0071] The filling level is adjusted to suit the desired use of the material. Preferably, the filling composite material has a filler content of 50-80% by weight, particularly preferably 70-80% by weight, and the dental cement has a filler content of 10-70% by weight, particularly preferably 60-70% by weight. The prosthesis material preferably has a filler content of 0-10% by weight, particularly preferably 0-5% by weight.

[0072] (f) At least one transition metal compound in an amount of 0.0001 to 1% by weight, preferably 0.0005 to 0.5% by weight, and particularly preferably 0.0007 to 0.02% by weight. Dental materials that additionally include this are particularly preferred.

[0073] These dental materials comprising the designated components are particularly preferred, where each component is preferably selected from the preferred and particularly preferred substances described above in each case. In all cases, mixtures of several substances, such as mixtures of monomers, can also be used as the respective components.

[0074] The material according to the present invention preferably exists in the form of two distinct components, the first of which comprises a hydroperoxide (catalyst paste) and the second of which comprises a thiourea derivative (base paste). Since the components preferably have a paste-like viscosity, they are also referred to as pastes herein. The catalyst paste and base paste compositions differ in that the catalyst paste comprises one or more hydroperoxides and the base paste comprises one or more thiourea derivatives.

[0075] The pastes are mixed together for use, thereby initiating the hardening reaction. The pastes are preferably blended so that the catalyst and base paste can be used in a 1:1 volume ratio. After mixing the pastes, the material has the composition defined above.

[0076] The dental materials according to the present invention are particularly characterized by not having a bitter taste after hardening. Furthermore, they have good hardening properties, that is, they have a favorable processing time in combination with a favorable hardening time. Moreover, after hardening, the materials have mechanical properties comparable to established redox-based materials, which are not limited to, for example, a mixture of acetylthiourea and cumene hydroperoxide (CHP).

[0077] The compositions according to the present invention are particularly suitable as dental materials, especially as dental cements, filling composites, and veneer materials, as well as as materials for the manufacture of prostheses, artificial teeth, inlays, onlays, crowns, and bridges. The compositions are primarily suitable for intraoral application by dentists to restore damaged teeth, i.e., therapeutic applications, such as dental cements, filling composites, and veneer materials. However, they can also be used non-therapeutically (outside the oral cavity) for the manufacture or repair of dental restorations such as prostheses, artificial teeth, inlays, onlays, crowns, and bridges.

[0078] The present invention will be described in more detail below with reference to examples of embodiments. [Examples]

[0079] Example 1 Synthesis of N-(2-methacryloyloxyhexanoyl)-thiourea [ka] Step 1: tert-butyl 6-hydroxyhexanoate [ka] ε-Caprolactone (181.88 g, 1.59 mol) was dissolved in tert-butanol (1600 ml). Potassium tert-butoxide (196.68 g, 1.75 mol) was added, and the suspension was heated under reflux for 5 hours. After cooling, toluene (1600 ml) and water (800 ml) were added, and the phases were separated. The organic phase was washed with water (2 x 1000 ml) and saturated sodium chloride aqueous solution (1000 ml), dried over anhydrous sodium sulfate, filtered, and concentrated using a rotary evaporator. The crude product was purified by vacuum distillation (boiling point: 70 °C / 0.03 mbar). 56.57 g (0.30 mol; 19% yield) of a colorless liquid was obtained. 1 H-NMR (CDCl3, 400 MHz): δ = 3.63 (t, 2H; J = 6.6 Hz; O-CH2), 2.67 (d, 1H; J = 0.8 Hz; OH), 2.22 (t, 2H; J = 7.4 Hz; (C=O)CH2), 1.63 - 1.56 (m, 4H; CH2), 1.44 (s, 9H; CH3), 1.43 - 1.34 (m, 2H; CH2). 13 C-NMR (CDCl3, 100.6 MHz): δ = 173.2 (C=O), 80.0 (C), 62.3 (CH2), 35.4 (CH2), 32.2 (CH2), 28.0 (CH3), 25.1 (CH2), 24.6 (CH2).

[0080] Step 2: 6-Methacryloyloxyhexanoate tert-butyl [ka] A solution of tert-butyl 6-hydroxyhexanoate (11.15 g, 59.2 mmol), triethylamine (7.18 g, 71.0 mmol), and N,N-dimethylaminopyridine (0.36 g, 3.0 mmol) in toluene (50 ml) was cooled to 0°C. A solution of methacrylic anhydride (10.95 g, 71.0 mmol) in toluene (10 ml) was added dropwise, and the reaction mixture was stirred at 0°C for 1 hour and then at ambient temperature for 1 hour. The reaction solution was washed with hydrochloric acid (1 N, 3 × 100 ml), sodium hydroxide solution (1 N, 3 × 100 ml), water (2 × 100 ml), and saturated sodium chloride aqueous solution (100 ml), dried over anhydrous sodium sulfate, filtered, and concentrated using a rotary evaporator. 14.35 g (56.0 mmol; 95% yield) of a colorless liquid was obtained. 1 H-NMR (CDCl3, 400 MHz): δ = 6.09 (m, 1H; =CH), 5.54 (m, 1H; =CH), 4.15 (t, 2H; J = 6.5 Hz; O-CH2), 2.23 (t, 2H; J = 7.4 Hz; (C=O)CH2), 1.94 (m, 3H; CH3), 1.74 - 1.60 (m, 4H; CH2), 1.44 (s, 9H; CH3), 1.43 - 1.37 (m, 2H; CH2). 13 C-NMR (CDCl3, 100.6 MHz): δ = 172.8 (C=O), 167.3 (C=O), 136.4 (=C), 125.1 (=CH2), 79.9 (C), 64.4 (CH2), 35.3 (CH2), 28.2 (CH2), 28.0 (CH3), 25.4 (CH2), 24.6 (CH2), 18.2 (CH3).

[0081] Step 3: 6-Methacryloyloxyhexanoic acid [ka] 6-Methacryloyloxyhexanoate tert-butyl ester (8.79 g, 34.3 mmol) was dissolved in dichloromethane (100 ml), and trifluoroacetic acid (20 ml) was added. The reaction mixture was stirred at ambient temperature. After 18 hours, the solution was concentrated using a rotary evaporator. Trifluoroacetic acid residue was removed by azeotropic distillation using toluene to obtain 6.87 g (34.3 mmol; 100% yield) of a slightly yellowish liquid. 1 H-NMR (CDCl3, 400 MHz): δ = 11.40 (br s, 1H; OH), 6.10 (m, 1H; =CH), 5.56 (m, 1H; =CH), 4.16 (t, 2H; J = 6.5 Hz; O-CH2), 2.39 (t, 2H; J = 7.4 Hz; (C=O)CH2), 1.94 (m, 3H; CH3), 1.76 - 1.66 (m, 4H; CH2), 1.49 - 1.41 (m, 2H; CH2). 13 C-NMR (CDCl3, 100.6 MHz): δ = 179.7 (C=O), 167.6 (C=O), 136.2 (=C), 125.4 (=CH2), 64.4 (CH2), 33.7 (CH2), 28.1 (CH2), 25.3 (CH2), 24.1 (CH2), 18.1 (CH3).

[0082] Step 4: 6-Methacryloyloxyhexanoate [ka] To a solution of 6-methacryloyloxyhexanoic acid (6.77 g, 33.8 mmol) and N,N-dimethylformamide (0.1 ml) in dichloromethane (100 ml), dichloride oxalate (5.15 g, 40.6 mmol) was added dropwise. The reaction solution was stirred at ambient temperature for 3 hours and then concentrated using a rotary evaporator. 7.18 g (32.8 mmol; 97% yield) of a yellowish liquid was obtained. 1 H-NMR (CDCl3, 400 MHz): δ = 6.08 (m, 1H; =CH), 5.56 (m, 1H; =CH), 4.15 (t, 2H; J = 6.5 Hz; O-CH2), 2.93 (t, 2H; J = 7.4 Hz; (C=O)CH2), 1.94 (m, 3H; CH3), 1.80 - 1.68 (m, 4H; CH2), 1.50 - 1.43 (m, 2H; CH2). 13 C-NMR (CDCl3, 100.6 MHz): δ = 173.4 (C=O), 167.2 (C=O), 136.2 (=C), 125.2 (=CH2), 64.0 (CH2), 46.7 (CH2), 28.0 (CH2), 24.7 (CH2), 24.5 (CH2), 18.1 (CH3).

[0083] Step 5: N-(2-methacryloyloxyhexanoyl)thiourea [ka] 6-Methacryloyloxyhexanoate chloride (7.05 g, 32.2 mmol) was dissolved in toluene (80 ml). Thiourea (2.70 g, 35.5 mmol) was added, and the suspension was heated under reflux for 3 hours. After cooling, the suspension was filtered. The filtration residue was washed with toluene (100 ml), dried, suspended in water (100 ml), filtered, washed with water (2 × 50 ml), and dried. The yellowish solid was dissolved in toluene (50 ml) at 60°C. The solution was cooled to 0°C and cold filtered. The filtration residue was washed with cold toluene (2 × 10 ml) and dried. 1.18 g (4.6 mmol; yield 14%) of a white solid (melting point: 97°C) was obtained. 1H-NMR (CDCl3, 400 MHz): δ = 9.95 (br s, 1H; NH), 9.61 (br s, 1H; NH), 7.54 (br s, 1H; NH), 6.10 (s, 1H; =CH), 5.56 (s, 1H; =CH), 4.16 (t, 2H; J = 6.5 Hz; O-CH2), 2.41 (t, 2H; J = 7.4 Hz; (C=O)CH2), 1.94 (s, 3H; CH3), 1.77 - 1.64 (m, 4H; CH2), 1.50 - 1.39 (m, 2H; CH2). 13 C-NMR (CDCl3, 100.6 MHz): δ = 182.0 (C=S), 173.8 (C=O), 167.5 (C=O), 136.3 (=C), 125.4 (=CH2), 64.2 (CH2), 36.8 (CH2), 28.1 (CH2), 25.3 (CH2), 24.1 (CH2), 18.2 (CH3).

[0084] Example 2 Synthesis of N-(4-vinylbenzoyl)thiourea [ka] Step 1: 4-Vinylbenzoyl chloride [ka] Dichloromethane (100 ml) and N,N-dimethylformamide (0.1 ml) were added to 4-vinylbenzoic acid (16.00 g, 0.108 mol), and dichloride oxalate (16.45 g, 0.130 mol) was added dropwise. The reaction mixture was stirred at room temperature for 4 hours and then filtered through silica gel. The filtrate was concentrated using a rotary evaporator to obtain 16.51 g (99.0 mmol; 92%) of a slightly brownish liquid. 1H-NMR (CDCl3, 400 MHz): δ = 8.05 (d, 2H; J = 8.5 Hz; Ar-H), 7.50 (d, 2H; J = 8.4 Hz; Ar-H), 6.75 (dd, 1H; J = 10.9 Hz, 17.6 Hz; =CH), 5.93 (d, 1H; J = 17.6Hz; =CH), 5.48 (d, 1H; J = 10.9Hz; =CH). 13 C-NMR (CDCl3, 100.6 MHz): δ = 167.8 (C=O), 144.3 (Ar-C), 135.3 (=CH), 132.0 (Ar-C), 131.8 (Ar-CH), 126.5 (Ar-CH), 118.4 (=CH2).

[0085] Step 2: N-(4-vinylbenzoyl)thiourea [ka] 4-Vinylbenzoyl chloride (16.41 g, 98.5 mmol) was dissolved in toluene (150 ml), and thiourea (8.25 g, 0.108 mol) was added. The suspension was refluxed for 5 hours, cooled, and filtered. The filtration residue was washed with toluene (100 ml), water (300 ml) was added, and the mixture was heated to 60°C. After cooling, the suspension was filtered. The filtration residue was washed with water (5 × 100 ml) and dried. Dichloromethane (500 ml) was added to the yellowish solid, and the mixture was heated under reflux. The suspension was filtered. The filtrate was concentrated using a rotary evaporator. The yellowish solid was dissolved in ethyl acetate (100 ml) and filtered through silica gel. The filtrate was concentrated using a rotary evaporator to obtain 3.90 g (18.9 mmol; 19%) of a white solid. 1H-NMR (DMSO-d6, 400 MHz): δ = 11.25 (s, 1H; NH), 9.91 (s, 1H; NH), 9.60 (s, 1H; NH), 7.95 (d, 2H; J = 8.4 Hz; Ar-H), 7.61 (d, 2H; J = 8.4 Hz; Ar-H), 6.82 (dd, 1H; J = 10.9 Hz, 17.7 Hz; =CH), 6.02 (d, 1H; J = 17.5Hz; =CH), 5.44 (d, 1H; J = 11.2Hz; =CH). 13 C-NMR (DMSO-d6, 100.6 MHz): δ = 182.5 (C=S), 167.8 (C=O), 141.9 (m, Ar-C), 136.9 (m, =CH), 135.4 (m, Ar-C), 131.7 - 125.3 (m, Ar-CH), 119.4 - 116.2 (m, =CH2).

[0086] Example 3 N-(2-methacryloyloxyethoxysuccinoyl)thiourea [ka] Step 1: 3-(2-methacryloyloxyethyloxycarbonyl)propionate [ka] 11.51 g, 50.0 mmol of mono(methacryloyloxyethyl) succinate was dissolved in 80 ml of dichloromethane. 0.1 ml of N,N-dimethylformamide was added, and 6.35 g, 50.0 mmol of dichloride oxalate was added dropwise. The reaction solution was stirred at ambient temperature for 3 hours, and then concentrated using a rotary evaporator. 12.39 g (49.8 mmol; 100%) of a colorless liquid was obtained. 1H-NMR (CDCl3, 400 MHz): δ = 6.03 (s, 1H; =CH), 5.61 (s, 1H; =CH), 4.37 (s, 4H; OCH2), 3.23 (t, 2H; J = 6.5 Hz; CH2), 2.72 (t, 2H; J = 6.5 Hz; CH2), 1.95 (s, 3H; CH3). 13 C-NMR (CDCl3, 100.6 MHz): δ = 172.8 (C=O), 170.5 (C=O), 166.9 (C=O), 135.7 (=C), 126.1 (=CH2), 62.7 (O-CH2), 62.0 (O-CH2), 41.5 (CH2), 29.1 (CH2), 18.1 (CH3).

[0087] Step 2: N-(2-methacryloyloxyethoxysuccinoyl)thiourea [ka] 3-(2-methacryloyloxyethyloxycarbonyl)propionate chloride (12.43 g, 50.0 mmol) was dissolved in toluene (100 ml). Thiourea (4.19 g, 55.0 mmol) was added, and the suspension was heated under reflux for 2 hours. After cooling, the suspension was filtered. The filtration residue was washed with toluene (100 ml), dried, and 2.44 g (8.4 mmol; 17%) of a white solid (melting point: 151°C) was obtained. 1 H-NMR (DMSO-d6, 400 MHz): δ = 11.18 (s, 1H; NH), 9.53 (s, 1H; NH), 9.35 (s, 1H; NH), 6.03 (m, 1H; =CH), 5.69 (m, 1H; =CH), 4.28 (s, 4H; O-CH2), 2.71-2.54 (m, 4H; CH2), 1.88 (s, 3H; CH3). 13C-NMR (DMSO-d6, 100.6 MHz): δ = 182.0 (C=S), 173.7 (C=O), 172.4 (C=O), 166.8 (m, C=O), 135.6 (m, =C), 128.0 (m, =CH2), 126.4 (m, =CH2), 62.6 (m, O-CH2), 30.0 (m, N-CH2), 17.7 (CH3).

[0088] Example 4 (Comparative Example) Synthesis of 4-oxo-9-thioxo-5-oxa-3,8,10-triazatrideca-12-en-1-yl methacrylate [ka] N-allyl-N'-(2-hydroxyethyl)thiourea (8.01 g, 50.0 mmol) was dissolved in anhydrous tetrahydrofuran (80 ml), and isocyanate ethyl methacrylate (7.76 g, 50.0 mmol) was added dropwise. Dibutyltin dilaurate (0.24 g, 2.0 mmol) was added, and the reaction mixture was stirred at room temperature. After 20 hours, the colorless, transparent solution was concentrated using a rotary evaporator. The colorless oil was dissolved in ethyl acetate (50 ml) and filtered through silica gel. The filtrate was concentrated using a rotary evaporator to obtain 15.45 g (48.9 mmol; 98%) of a waxy white solid. 1 H-NMR (CDCl3, 400 MHz): δ = 7.04-6.65 (m, 2H; NH), 6.13 (s, 1H; =CH), 5.92-5.80 (m, 1H; =CH), 5.62 (s, 1H; =CH), 5.60-5.49 (m, 1H; NH), 4.34-4.19 (m, 4H; CH2), 4.19-3.64 (m, 4H; CH2), 3.54-3.32 (m, 2H; N-CH2), 1.95 (s, 3H; CH3). 13C-NMR (CDCl3, 100.6 MHz): δ = 182.0 (C=S), 167.3 (C=O), 156.7 (C=O), 135.6 (=C), 133.1 (=CH), 126.2 (=CH2), 117.0 (=CH2), 63.3 (m, O-CH2), 63.2 (m, O-CH2), 46.4 (N-CH2), 44.4 (N-CH2), 40.1 (N-CH2), 18.1 (CH3).

[0089] Example 5 Thiourea-based composite cement according to the present invention In all cases, the chemically hardened composite cement, consisting of a base paste and a catalyst paste, was prepared from a mixture of dimethacrylate UDMA (addition product of 2-hydroxyethyl methacrylate and 2,2,4-trimethylhexamethylene-1,6-diisocyanate), bis-GMA (addition product of methacrylic acid and bisphenol A diglycidyl ether) and 2-(2-biphenyloxy)-ethyl methacrylate (MA-836), as well as stabilizers MEHQ (hydroquinone monomethyl ether) and TEMPO (2,2,6,6-tetramethylpiperidine-1-yl)oxyl), filler GM27884 0.7 μm sil. (silane-treated glass filler GM G018-056, average particle size 0.7 μm, Schott), and initiator components CHP (cumene hydroperoxide, 80%), copper(II) acetylacetonate (Cu(acac)2), and in each case, a thiourea compound. Table 1: Composition of Cata-1 catalyst paste [Table 1] Table 2: Composition of base paste [Table 2] *) Comparative example

[0090] The catalyst paste Cat-1 was blended with various base pastes in a 1:1 volume ratio, and the processing time of the resulting cement was determined. The processing time (PT) of the paste mixture was determined using a rheometer (Motion Compact Rheometer MCR 302, Anton Paar). For this purpose, the catalyst paste and base paste were manually blended in a 1:1 ratio on a mixing block. The material was then applied to a mold made of Delrin with a roughened surface on the rheometer. A measuring bob shaft, fixed to a spindle with a similarly rough surface, compressed the sample, and the storage modulus was determined by slight rotation. Inflection points were defined in each case, at the start of the stable phase and after reaching a certain gradient. The inflection points were then connected by a straight line. The measurement point furthest from this line was defined as the PT. The entire measurement was performed at 28.7°C in a temperature-controlled chamber. The results are shown in Table 3. Table 3: Cement treatment time (PT) [Table 3] *) Comparative example

[0091] The flexural strength and flexural modulus of the cement were determined according to the EN ISO-4049 standard (Dental - Polymer-based fillings, restoratives and luting materials). For this purpose, catalyst paste Cat-1 was blended with various base pastes in a 1:1 volume ratio in each case, and test specimens were prepared from the mixtures according to the standard. These were cured by storage in a heating cabinet at 37°C for 45 minutes, and their mechanical properties were measured. The results are summarized in Table 4.

[0092] The results demonstrate that, after hardening, the composite cement according to the present invention has far superior mechanical properties than comparative materials having known polymerizable thiourea derivatives, which in all respects are comparable to the mechanical properties of cements based on trial and tested initiator systems of CHP using hexanoylthiourea. Table 4: Bending strength (FS, MPa) and flexural modulus (FM, MPa) of hardening cement [Table 4] *) Comparative example a) DS: Dry storage at room temperature for 24 hours. b) WS: Water storage at 37°C for 24 hours

Claims

1. A radically polymerizable dental material comprising a combination of a thiourea derivative and a hydroperoxide as an initiator system for radical polymerization, the combination having the following formula (I): 【Chemistry 30】 where the variables have the following meanings: R is an (n+1)-valent, aromatic, aliphatic, linear or branched C which may be absent or interrupted by one or more, preferably 1 to 8, particularly preferably 1 to 6, ether, thioether, ester, amide or urethane groups. 1 ~C 50 is a hydrocarbon radical, PG is a radically polymerizable (meth)acrylate, (meth)acrylamide or vinyl group; n is 1, 2, or 3. Radically polymerizable dental material, characterized in that it contains a thiourea derivative according to

2. The variables have the following meaning: R is an (n+1)-valent, aromatic, aliphatic, linear or branched C which may be interrupted by one or more, preferably 1 to 6, particularly preferably 1 to 3, ether, ester or urethane groups. 1 ~C 30 is a hydrocarbon radical, PG is a radically polymerizable methacrylate, methacrylamide or vinyl group; n is 1 or 2 The dental material of claim 1 ,

3. The variables have the following meaning: R is an (n+1)-valent, aromatic, aliphatic, linear or branched C which may be interrupted by 1 to 6 ether groups, or an ester or urethane group. 1 ~C 20 is a hydrocarbon radical, PG is a radically polymerizable methacrylate or vinyl group; n is 1 or or R is a phenylene radical, preferably a p-phenylene radical, or a radical of the formula -Ph-CH 2 - is a radical having PG is a vinyl group; n is 1 The dental material according to claim 2 , having

4. Formula R 1 (OOH) m as hydroperoxide, wherein R 1 4. A dental material according to any one of the preceding claims, wherein is an aliphatic or aromatic hydrocarbon radical and m is 1 or 2.

5. 5. Dental material according to claim 4, comprising as hydroperoxide t-amyl hydroperoxide, 1,1,3,3-tetramethylbutyl hydroperoxide, t-butyl hydroperoxide, t-hexylhydroxyperoxide, 2,5-dimethyl-2,5-di(hydroperoxy)hexane, diisopropylbenzene monohydroperoxide, paramenthane hydroperoxide, p-isopropylcumene hydroperoxide or mixtures thereof, preferably cumene hydroperoxide (CHP).

6. The following formula (II) 【Chemistry 31】 wherein the variables have the following meanings: Q 1 may be interrupted by one or more S and / or O atoms and is unsubstituted or preferably -OH, -OR 2 p-valent, aromatic, aliphatic, linear or branched C which may be substituted by one or more substituents selected from -Cl and -Br; 1 ~C 14 A hydrocarbon radical, where R 2 is an aliphatic, linear or branched C 1 ~C 10 is a hydrocarbon radical, X and Y are each independently not present in any case, -O-, -COO-, or -CONR 3 -, or -O-CO-NR 4 -, where R 3 and R 4 are each independently H or C 1 ~C 5 an alkyl radical, preferably H, methyl and / or ethyl, particularly preferably H; X and Y are preferably not present at the same time, Q 2 may be absent, interrupted by S and / or O atoms, unsubstituted or represented by -OH, -OR 5 aliphatic, linear or branched C, which may be substituted with -Cl and / or -Br; 1 ~C 14 an alkylene radical, where R 5 is an aliphatic, linear or branched C 1 ~C 10 is a hydrocarbon radical, Q 3 is C 1 ~C 3 an alkylene group or absent, preferably -CH 2 - or does not exist, Here, Q 2 is not present, then X and / or Y are not present; p is 1, 2, 3 or 4; and here The said substituents on the aromatic compound occur at the 2, 3, or 4 position.

2. Dental material according to any one of the preceding claims, comprising a hydroperoxide according to

7. 10. Dental material according to any one of the preceding claims, further comprising a transition metal compound, preferably a compound of a transition metal having at least two stable oxidation states, preferably a compound of copper, iron, cobalt, nickel, manganese or mixtures thereof.

8. 0.001 to 5% by weight, particularly preferably 0.005 to 3.0% by weight and very particularly preferably 0.1 to 3.0% by weight of at least one thiourea derivative of the formula (I), 0.01 to 5 wt.-%, preferably 0.05 to 4.0 wt.-%, and particularly preferably 0.1 to 3.0 wt.-% of hydroperoxide, Optionally, 0.0001 to 1% by weight, preferably 0.0005 to 0.5% by weight and particularly preferably 0.0007 to 0.020% by weight of a transition metal compound, 5. Dental material according to any one of the preceding claims, comprising in each case relative values ​​with respect to the total mass of the material.

9. 10. Dental material according to any one of the preceding claims, further comprising at least one radically polymerizable monomer, preferably at least one mono- or polyfunctional (meth)acrylate, particularly preferably at least one dimethacrylate or a mixture of mono- and dimethacrylates.

10. As radically polymerizable monomers, methyl, ethyl, 2-hydroxyethyl, butyl, benzyl, tetrahydrofurfuryl or isobornyl (meth)acrylate, p-cumylphenoxyethylene glycol methacrylate (CMP-1E), 2-(2-biphenyloxy)ethyl methacrylate, bisphenol A dimethacrylate, bis-GMA (addition product of methacrylic acid and bisphenol A diglycidyl ether), ethoxylated or propoxylated bisphenol A dimethacrylate, 2-[4-(2-methacryloyloxyethoxyethoxy)phenyl]-2-[4-(2-methacryloyloxyethoxy)phenyl]propane) (SR-348c), 2,2-bis ... cyclopropoxy)phenyl]propane, UDMA (addition product of 2-hydroxyethyl methacrylate and 2,2,4-trimethylhexamethylene-1,6-diisocyanate), V-380 (addition product of a mixture of 0.7 mol of 2-hydroxyethyl methacrylate and 0.3 mol of 2-hydroxypropyl methacrylate with 1 mol of α,α,α',α'-tetramethyl-m-xylylene diisocyanate), di-, tri- or tetraethylene glycol dimethacrylate, trimethylolpropane trimethacrylate, pentaerythritol tetramethacrylate, glycerol di- and trimethacrylate, 1,4-butanediol dimethacrylate, 1,10-decanediol dimethacrylate (D 3 10. The dental material of claim 9, comprising bis(methacryloyloxymethyl)tricyclo-[5.2.1.02,6]decane (MA), bis(methacryloyloxymethyl)tricyclo-[5.2.1.02,6]decane (DCP), polyethylene glycol or polypropylene glycol dimethacrylate, polyethylene glycol 200 dimethacrylate, polyethylene glycol 400 dimethacrylate (PEG200DMA or PEG400DMA), 1,12-dodecanediol dimethacrylate or mixtures thereof.

11. 11. Dental material according to claim 9 or 10, further comprising at least one acid group-containing radically polymerizable monomer, preferably a polymerizable carboxylic acid, a phosphonic acid, a polymerizable phosphoric ester or an anhydride of these substances.

12. At least one organic or inorganic filler, preferably an oxide, e.g., SiO 2 , ZrO 2 and TiO 2 or SiO 2 , ZrO 2 , ZnO and / or TiO 2 mixed oxides of, nanoparticles or microfine fillers, for example pyrogenic or precipitated silica, glass powders, for example quartz, glass ceramics or radiopaque glass powders, preferably barium or strontium aluminum silicate glass powders, radiopaque fillers, for example ytterbium trifluoride, tantalum(V) oxide, barium sulfate, ytterbium(III) oxide or tantalum(V) oxide with SiO 2 2. Dental material according to any one of the preceding claims, further comprising a mixed oxide of, a milled prepolymer or a pearl polymer.

13. (a) 0.001 to 5.0% by weight, preferably 0.005 to 3.0% by weight, particularly preferably 0.1 to 3.0% by weight, of at least one thiourea derivative of the formula (I), (b) 0.01 to 5.0% by weight, preferably 0.05 to 4.0% by weight, particularly preferably 0.1 to 3.0% by weight, of at least one hydroperoxide, (c) 5 to 95% by weight, preferably 10 to 95% by weight, and particularly preferably 10 to 90% by weight, of at least one radically polymerizable monomer, (d) 0 to 80 wt. % of a filler(s); and (e) 0.01 to 5 wt.-%, preferably 0.1 to 3 wt.-%, particularly preferably 0.1 to 2 wt.-%, of additive(s); 5. Dental material according to any one of the preceding claims, comprising in each case relative values ​​with respect to the total mass of the material.

14. Dental material according to claim 13, comprising 50-80% by weight (filled composite material) or 10-70% by weight (cement) or 0-10% by weight of a filler (prosthetic material).

15. 13. A dental material according to any one of the preceding claims for use in treatment.

16. Non-therapeutic use of a dental material according to any one of claims 1 to 14 for the extraoral manufacture or repair of dental restorations such as prostheses, artificial teeth, inlays, onlays, crowns, bridges and complete dentures.